Skip to main content
. Author manuscript; available in PMC: 2018 Jan 9.
Published in final edited form as: Cancer Causes Control. 2014 Apr 11;25(6):709–725. doi: 10.1007/s10552-014-0374-6

Table 1.

Incidence rates of classical Hodgkin lymphoma (HL) overall and by selected histologic subtype, for Hispanics and whites, and race/ethnicity incidence rate ratios (IRR) and 95 % confidence intervals (CI), by gender and age, 1988–2004, California

All HL Nodular sclerosis HL Mixed cellularity HL
Hispanics Whites Hispanic vs.
White
Hispanics Whites Hispanic vs.
White
Hispanics Whites Hispanic vs.
White
N Rate* 95% CI N Rate* 95% CI IRR 95% CI N Rate* 95% CI N Rate* 95% CI IRR 95% CI N Rate* 95% CI N Rate* 95% CI IRR 95% CI
TOTAL
Age (10-year groups)
00–09 134 0.38 0.32–0.45 56 0.17 0.13–0.22 2.24 1.64–3.05 77 0.22 0.17–0.27 32 0.10 0.07–0.14 2.20 1.46–3.32 44 0.13 0.09–0.17 13 0.04 0.02–0.07 3.25 1.75–6.03
10–19 465 1.54 1.40–1.69 778 2.43 2.26–2.61 0.63 0.56–0.71 360 1.19 1.07–1.32 632 1.97 1.82–2.13 0.60 0.53–0.69 54 0.18 0.13–0.23 67 0.21 0.16–0.27 0.86 0.60–1.23
20–29 648 1.98 1.83–2.14 2,071 5.65 5.41–5.90 0.35 0.32–0.38 474 1.45 1.32–1.59 1,650 4.51 4.29–4.73 0.32 0.29–0.36 93 0.29 0.23–0.35 192 0.52 0.45–0.60 0.56 0.44–0.71
30–39 415 1.44 1.31–1.59 1,842 3.89 3.72–4.07 0.37 0.33–0.41 278 0.96 0.85–1.08 1,429 3.01 2.86–3.17 0.32 0.28–0.36 79 0.28 0.22–0.35 203 0.43 0.38–0.50 0.65 0.50–0.84
40–49 254 1.45 1.28–1.64 1,133 2.56 2.42–2.72 0.57 0.49–0.65 127 0.72 0.60–0.86 769 1.74 1.62–1.87 0.41 0.34–0.50 69 0.40 0.31–0.51 176 0.40 0.34–0.46 1.00 0.76–1.32
50–59 222 2.33 2.03–2.66 759 2.34 2.18–2.52 1.00 0.86–1.16 86 0.90 0.72–1.11 415 1.28 1.16–1.41 0.70 0.56–0.89 72 0.75 0.59–0.95 188 0.58 0.50–0.67 1.29 0.99–1.70
60–69 207 3.65 3.17–4.18 792 3.23 3.01–3.46 1.13 0.97–1.32 62 1.09 0.84–1.40 334 1.36 1.22–1.52 0.80 0.61–1.05 85 1.50 1.20–1.86 226 0.92 0.80–1.05 1.63 1.27–2.09
70–79 171 5.46 4.67–6.35 774 3.94 3.66–4.22 1.39 1.17–1.64 54 1.74 1.30–2.27 270 1.37 1.21–1.55 1.27 0.95–1.70 56 1.75 1.32–2.28 246 1.25 1.10–1.42 1.40 1.05–1.87
80+ 79 5.76 4.56–7.19 432 3.84 3.48–4.22 1.50 1.18–1.91 30 2.20 1.48–3.14 156 1.39 1.18–1.62 1.58 1.07–2.34 29 2.10 1.40–3.01 120 1.06 0.88–1.27 1.98 1.32–2.97
Age groups
00–14 298 0.61 0.54–0.69 268 0.54 0.48–0.61 1.13 0.96–1.33 195 0.40 0.35–0.46 202 0.41 0.36–0.47 0.98 0.80–1.19 75 0.15 0.12–0.19 34 0.07 0.05–0.10 2.14 1.43–3.21
15–39 1,364 1.76 1.67–1.86 4,479 4.48 4.35–4.62 0.39 0.37–0.42 994 1.28 1.20–1.36 3,541 3.55 3.43–3.67 0.36 0.34–0.39 195 0.26 0.22–0.29 441 0.44 0.40–0.48 0.59 0.50–0.70
40–54 360 1.59 1.43–1.76 1,531 2.47 2.35–2.60 0.64 0.57–0.72 170 0.74 0.63–0.86 990 1.60 1.50–1.70 0.46 0.39–0.54 105 0.48 0.39–0.58 272 0.44 0.39–0.49 1.09 0.87–1.37
55+ 573 4.30 3.94–4.68 2,359 3.35 3.21–3.49 1.28 1.17–1.41 189 1.43 1.23–1.66 954 1.36 1.28–1.45 1.05 0.90–1.23 206 1.52 1.32–1.76 684 0.97 0.90–1.04 1.57 1.34–1.83
TOTAL 2,595 2.02 1.93–2.11 8,637 2.96 2.90–3.02 0.68 0.65–0.71 1,548 1.01 0.95–1.07 5,687 1.99 1.93–2.04 0.51 0.48–0.54 581 0.55 0.50–0.61 1,431 0.47 0.45–0.50 1.17 1.06–1.29
MALES
Age (10-year groups)
00–09 100 0.56 0.45–0.68 38 0.22 0.16–0.30 2.55 1.75–3.70 57 0.32 0.24–0.41 18 0.10 0.06–0.17 3.20 1.88–5.44 36 0.20 0.14–0.28 10 0.06 0.03–0.11 3.33 1.65–6.72
10–19 243 1.54 1.35–1.75 376 2.27 2.05–2.52 0.68 0.58–0.80 175 1.11 0.95–1.29 282 1.71 1.51–1.92 0.65 0.54–0.78 37 0.23 0.17–0.32 46 0.28 0.20–0.37 0.82 0.53–1.27
20–29 343 1.92 1.72–2.13 1,045 5.52 5.19–5.87 0.35 0.31–0.39 217 1.22 1.06–1.39 779 4.13 3.85–4.43 0.30 0.25–0.34 75 0.42 0.33–0.53 129 0.68 0.57–0.81 0.62 0.46–0.82
30–39 219 1.45 1.26–1.65 982 4.07 3.82–4.33 0.36 0.31–0.41 131 0.86 0.72–1.03 696 2.88 2.67–3.10 0.30 0.25–0.36 51 0.33 0.25–0.44 149 0.62 0.53–0.73 0.53 0.39–0.73
40–49 151 1.72 1.45–2.02 663 2.97 2.75–3.20 0.58 0.49–0.69 69 0.78 0.61–0.99 398 1.78 1.61–1.97 0.44 0.34–0.57 48 0.56 0.41–0.75 128 0.57 0.48–0.68 0.98 0.71–1.37
50–59 130 2.84 2.37–3.37 477 2.97 2.71–3.25 0.96 0.79–1.16 43 0.94 0.68–1.26 236 1.47 1.29–1.67 0.64 0.46–0.89 38 0.83 0.59–1.14 128 0.80 0.67–0.95 1.04 0.72–1.49
60–69 123 4.75 3.94–5.67 464 4.01 3.66–4.39 1.18 0.97–1.45 39 1.50 1.06–2.05 192 1.66 1.43–1.91 0.90 0.64–1.27 44 1.72 1.25–2.30 138 1.19 1.00–1.41 1.45 1.03–2.03
70–79 96 7.33 5.93–8.97 387 4.54 4.10–5.02 1.61 1.29–2.02 27 2.06 1.35–3.01 134 1.58 1.32–1.87 1.30 0.86–1.97 34 2.55 1.76–3.57 120 1.41 1.17–1.68 1.81 1.24–2.65
80+ 40 8.01 5.71–10.93 198 5.13 4.43–5.90 1.56 1.11–2.19 15 3.07 1.71–5.07 65 1.68 1.29–2.15 1.83 1.04–3.20 17 3.30 1.91–5.30 61 1.57 1.19–2.02 2.10 1.23–3.60
Age groups
00–14 195 0.78 0.67–0.89 150 0.59 0.50–0.69 1.32 1.07–1.64 120 0.48 0.40–0.57 96 0.38 0.31–0.46 1.26 0.97–1.65 57 0.22 0.17–0.29 28 0.11 0.07–0.16 2.00 1.27–3.14
15–39 710 1.71 1.58–1.84 2,291 4.44 4.26–4.63 0.39 0.35–0.42 460 1.11 1.01–1.22 1,679 3.27 3.11–3.43 0.34 0.31–0.38 142 0.34 0.28–0.40 306 0.59 0.52–0.66 0.58 0.47–0.70
40–54 213 1.89 1.64–2.16 913 2.93 2.74–3.12 0.65 0.56–0.75 89 0.77 0.62–0.95 518 1.66 1.52–1.81 0.46 0.37–0.58 67 0.60 0.47–0.77 197 0.63 0.55–0.73 0.95 0.72–1.26
55+ 327 5.69 5.05–6.39 1,276 4.14 3.91–4.37 1.37 1.22–1.55 104 1.83 1.47–2.25 507 1.63 1.49–1.78 1.12 0.91–1.39 114 2.02 1.65–2.46 378 1.23 1.10–1.36 1.64 1.33–2.02
TOTAL 1,445 2.40 2.24–2.56 4,630 3.22 3.13–3.32 0.75 0.70–0.79 773 1.05 0.96–1.16 2,800 1.95 1.88–2.02 0.54 0.50–0.58 380 0.73 0.64–0.83 909 0.63 0.59–0.67 1.16 1.03–1.31
FEMALES
Age (10-year groups)
00–09 34 0.20 0.14–0.28 18 0.11 0.07–0.18 1.82 1.03–3.22 20 0.12 0.07–0.18 14 0.09 0.05–0.14 1.33 0.67–2.64 8 0.05 0.02–0.09 <5 0.02 0.00–0.05 2.50 0.66–9.42
10–19 222 1.54 1.35–1.76 402 2.60 2.35–2.86 0.59 0.50–0.70 185 1.29 1.11–1.49 350 2.26 2.03–2.51 0.57 0.48–0.68 17 0.12 0.07–0.19 21 0.14 0.08–0.21 0.86 0.45–1.62
20–29 305 2.06 1.83–2.30 1,026 5.78 5.43–6.15 0.36 0.31–0.40 257 1.74 1.53–1.96 871 4.91 4.59–5.25 0.35 0.31–0.41 18 0.12 0.07–0.19 63 0.36 0.27–0.46 0.33 0.20–0.56
30–39 196 1.44 1.24–1.66 860 3.71 3.46–3.96 0.39 0.33–0.45 147 1.07 0.90–1.26 733 3.16 2.93–3.39 0.34 0.28–0.40 28 0.22 0.14–0.31 54 0.23 0.18–0.31 0.96 0.61–1.51
40–49 103 1.18 0.96–1.44 470 2.15 1.96–2.35 0.55 0.44–0.68 58 0.66 0.50–0.85 371 1.70 1.53–1.88 0.39 0.29–0.51 21 0.25 0.15–0.38 48 0.22 0.16–0.29 1.14 0.68–1.90
50–59 92 1.86 1.50–2.28 282 1.73 1.53–1.94 1.08 0.85–1.36 43 0.87 0.63–1.17 179 1.10 0.95–1.28 0.79 0.57–1.10 34 0.69 0.48–0.96 60 0.37 0.28–0.47 1.86 1.22–2.84
60–69 84 2.73 2.18–3.38 328 2.52 2.25–2.81 1.08 0.85–1.38 23 0.75 0.47–1.12 142 1.10 0.93–1.30 0.68 0.44–1.06 41 1.33 0.95–1.80 88 0.67 0.54–0.83 1.99 1.37–2.88
70–79 75 4.12 3.24–5.17 387 3.46 3.13–3.83 1.19 0.93–1.52 27 1.50 0.99–2.19 136 1.22 1.02–1.44 1.23 0.81–1.86 22 1.18 0.74–1.79 126 1.13 0.94–1.34 1.04 0.66–1.64
80+ 39 4.48 3.19–6.13 234 3.20 2.80–3.64 1.40 1.00–1.96 15 1.72 0.96–2.84 91 1.24 1.00–1.52 1.39 0.80–2.40 12 1.38 0.71–2.41 59 0.81 0.62–1.04 1.70 0.92–3.17
Age groups
00–14 103 0.44 0.36–0.53 118 0.49 0.41–0.59 0.90 0.69–1.17 75 0.32 0.25–0.40 106 0.44 0.36–0.54 0.73 0.54–0.98 18 0.08 0.05–0.12 6 0.02 0.01–0.05 4.00 1.59–10.08
15–39 654 1.82 1.68–1.97 2,188 4.53 4.34–4.72 0.40 0.37–0.44 534 1.47 1.35–1.61 1,862 3.85 3.68–4.03 0.38 0.35–0.42 53 0.16 0.12–0.21 135 0.28 0.23–0.33 0.57 0.42–0.79
40–54 147 1.29 1.09–1.52 618 2.01 1.85–2.17 0.64 0.54–0.77 81 0.70 0.56–0.88 472 1.53 1.40–1.68 0.46 0.36–0.58 38 0.35 0.25–0.48 75 0.24 0.19–0.31 1.46 0.99–2.15
55+ 246 3.28 2.87–3.72 1,083 2.73 2.57–2.90 1.20 1.05–1.38 85 1.15 0.91–1.43 447 1.14 1.04–1.26 1.01 0.80–1.27 92 1.18 0.94–1.45 306 0.77 0.68–0.86 1.53 1.21–1.93
TOTAL 1,150 1.72 1.61–1.84 4,007 2.73 2.65–2.82 0.63 0.59–0.67 775 0.99 0.91–1.07 2,887 2.04 1.96–2.12 0.49 0.45–0.53 201 0.40 0.34–0.46 522 0.32 0.29–0.35 1.25 1.06–1.47
*

Rates are per 100,000 and age adjusted to the 2000 US Standard Population (19 age groups–Census P25–1130); confidence intervals (Tiwari modification) are 95 % for rates

Bolded IRR and 95 % CI are statistically significant

To comply with California Cancer Registry confidentiality regulations, case counts fewer than 5 are not presented